🇺🇸 FDA
Patent

US 8303995

Nitrite formulations and their use as nitric oxide prodrugs

granted A61KA61K31/195A61K31/198

Quick answer

US patent 8303995 (Nitrite formulations and their use as nitric oxide prodrugs) held by The Board of Regents of the University of Texas System expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/195, A61K31/198, A61K31/375, A61K31/714